HomeHEM • CVE
add
Hemostemix Inc
Previous close
$0.13
Day range
$0.12 - $0.12
Year range
$0.035 - $0.43
Market cap
17.09M CAD
Avg Volume
250.88K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.04M | 218.53% |
Net income | -1.28M | -170.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.04M | -218.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 965.16K | 2,652.19% |
Total assets | 1.23M | 1,201.79% |
Total liabilities | 8.69M | 9.53% |
Total equity | -7.47M | — |
Shares outstanding | 95.06M | — |
Price to book | -1.56 | — |
Return on assets | -233.17% | — |
Return on capital | 102.73% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.28M | -170.13% |
Cash from operations | 337.47K | 380.41% |
Cash from investing | -145.58K | — |
Cash from financing | 67.58K | — |
Net change in cash | 259.46K | 315.60% |
Free cash flow | 706.08K | 941.31% |
About
Headquarters
Website
